Sphingosine Kinase 2 Modulates Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy
Author(s) -
Jeanette Eresch,
Martin Stumpf,
Alexander Koch,
Rajkumar Vutukuri,
Nerea Ferreirós,
Yannick Schreiber,
Katrin Schröder,
Kavi Devraj,
Rüdiger Popp,
Andrea Huwiler,
LarsOlof Hattenbach,
Josef Pfeilschifter,
Waltraud Pfeilschifter
Publication year - 2018
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.17-22544
Subject(s) - angiogenesis , neovascularization , vascular endothelial growth factor a , sphingosine , vascular endothelial growth factor , retinal , cancer research , microbiology and biotechnology , biology , biochemistry , receptor , vegf receptors
Neovascularization is a major cause of blindness in various ocular diseases. Bioactive sphingosine 1-phosphate (S1P), synthesized by two sphingosine kinases (Sphk1, Sphk2), emerged as a key player in a multitude of cellular processes, including cell survival, proliferation, inflammation, migration, and angiogenesis. We investigated the role of Sphk2, S1P, and S1P receptors (S1PR) during retinal neovascularization using the oxygen-induced retinopathy mouse model (OIR).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom